3M publishes safety data on pressurised meter dose inhalers

Published: 29-Jan-2018
Drug Delivery Research & Development Pharmaceutical Dosage Forms

3M offers a full range of feasibility, development and manufacturing capabilities to help bring products to market, such as the 3M intelligent inhaler

Published in The British Pharmacological Society 3M tested the systemic pharmacodynamic effects of the salmeterol component of two pressurised metered dose inhalers that delivered a combination of salmeterol and fluticasone propionate (SM/FP).

The paper reports on the results of the safety equivalence study that was pivotal in the approval of a new SM/FP inhalation product.

Click here to download the full paper.

  • Companies:
  • 3M Group
See more

You may also like

Manufacturing

3M begins manufacturing authorised generic of PROVENTIL HFA Inhaler

Read more

Trending Articles

  1. Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
  2. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  3. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  4. Efficient PFAS-free degassing of aqueous solutions New silicone-based degassing chamber eliminates the risk of PFAS contamination
  5. BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical characterisation

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

3M begins manufacturing authorised generic of PROVENTIL HFA Inhaler
Media

Moving the needle in 2019

By now, says 3M’s Dr Steven Wick, it’s no secret that technological advances are changing the landscape of drug delivery
Drug Delivery

3M Drug Delivery Systems launches re-designed rescue inhaler

Proventil HFA (albuterol sulfate) Inhalation Aerosol now manufactured with top-mounted dose indicator telling patients when to order a refill
Drug Delivery

Understanding in-vitro performance of inhaler products

Andy Cooper and Chris Blatchford of 3M group investigate Acoustic methodology for measuring discharge rate, and predicting spray velocity effects on potential lung deposition
Drug Delivery

Uniformity of delivered dose for pressurised metered dose inhalers

Jim Clay and Andy Cooper from 3M investigate pMDI uniformity of delivered dose method development using an automated dose collection apparatus
Drug Delivery

3M unveils intelligent inhaler

Technology aims to solve patient competence and adherence challenges, minimising burden of financial pressures faced by health care providers
Drug Delivery

3M Drug Delivery Systems announces collaboration with Panacea Pharmaceuticals on new cancer vaccine

3M Drug Delivery Systems announces a new phase of an ongoing collaboration with Panacea Pharmaceuticals in delivering an investigational therapeutic cancer vaccine directly to the dermis via the 3M Hollow Microstructured Transdermal System (hMTS)
Subscribe now